Global Home Pregnancy Tests Market Growth (Status and Outlook) 2025-2031

The global Home Pregnancy Tests market size is predicted to grow from US$ 257 million in 2025 to US$ 326 million in 2031; it is expected to grow at a CAGR of 4.0% from 2025 to 2031.

Home Pregnancy Tests are simple and convenient medical devices used to determine whether a woman is pregnant. The test works by detecting the presence of human chorionic gonadotropin (hCG) in urine, a hormone that increases significantly during early pregnancy. Home pregnancy tests are commonly available in the form of test strips, test sticks, or digital devices. They are easy to use, highly accurate, and offer quick results, providing a private and accessible solution without the need for specialized equipment or medical facilities. These tests are widely used in home settings as an initial screening method.

United States market for Home Pregnancy Tests is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Home Pregnancy Tests is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Home Pregnancy Tests is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Home Pregnancy Tests players cover Swiss Precision Diagnostics GmbH (SPD), BIOSYNEX, Mentholatum, Jant Pharmacal, Healthpoint Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Home Pregnancy Tests Industry Forecast” looks at past sales and reviews total world Home Pregnancy Tests sales in 2024, providing a comprehensive analysis by region and market sector of projected Home Pregnancy Tests sales for 2025 through 2031. With Home Pregnancy Tests sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Home Pregnancy Tests industry.

This Insight Report provides a comprehensive analysis of the global Home Pregnancy Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Home Pregnancy Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Home Pregnancy Tests market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Home Pregnancy Tests and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Home Pregnancy Tests.

This report presents a comprehensive overview, market shares, and growth opportunities of Home Pregnancy Tests market by product type, application, key players and key regions and countries.

Segmentation by Type:
Pregnancy Test Strip
Pregnancy Test Stick

Segmentation by Application:
Online Sales
Offline Sales

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Swiss Precision Diagnostics GmbH (SPD)
BIOSYNEX
Mentholatum
Jant Pharmacal
Healthpoint Ltd
AccuBioTech Co.,Ltd
BTNX Inc.
Hangzhou Testsea Biological Technology
Runbio Biotech
W.H.P.M.BIORESEARCH&TECHNOLOGY
China Resources Zizhu Pharmaceutical
Blue Cross Bio-Medical (Beijing)
AIDE Diagnostic
EGENS GROUP

Please note: The report will take approximately 2 business days to prepare and deliver.